These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 11250605)

  • 1. [Aromatase inhibitors: pharmacological aspects].
    de Crémoux P
    Bull Cancer; 2000 Dec; 87 Spec No():23-29. PubMed ID: 11250605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of aromatase inhibitors in breast carcinoma.
    Santen RJ; Harvey HA
    Endocr Relat Cancer; 1999 Mar; 6(1):75-92. PubMed ID: 10732791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preclinical evaluation of aromatase inhibitors antitumor activity].
    Auvray P; Bichat F; Genne P
    Bull Cancer; 2000 Dec; 87 Spec No():7-22. PubMed ID: 11250604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aromatase inhibitors].
    Feutrie ML; Bonneterre J
    Bull Cancer; 1999 Oct; 86(10):821-7. PubMed ID: 10572233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmenopausal estrogen synthesis and metabolism: alterations caused by aromatase inhibitors used for the treatment of breast cancer.
    Lønning PE; Dowsett M; Powles TJ
    J Steroid Biochem; 1990 Mar; 35(3-4):355-66. PubMed ID: 2139151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of the actions of aromatase inhibitors 4-hydroxyandrostenedione, fadrozole, and aminoglutethimide on aromatase in JEG-3 cell culture.
    Yue W; Brodie AM
    J Steroid Biochem Mol Biol; 1997; 63(4-6):317-28. PubMed ID: 9459198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are differences in the available aromatase inhibitors and inactivators significant?
    Johnson PE; Buzdar A
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4360s-4368s; discussion 4411s-4412s. PubMed ID: 11916226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in vitro method to determine the selective inhibition of estrogen biosynthesis by aromatase inhibitors.
    Häusler A; Schenkel L; Krähenbühl C; Monnet G; Bhatnagar AS
    J Steroid Biochem; 1989 Jul; 33(1):125-31. PubMed ID: 2527324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The control and biological importance of intratumoural aromatase in breast cancer.
    Dowsett M; Lee K; Macaulay VM; Detre S; Rowlands M; Grimshaw R
    J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):145-50. PubMed ID: 8603035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anastrozole--a new generation in aromatase inhibition: clinical pharmacology.
    Dowsett M; Lønning PE
    Oncology; 1997; 54 Suppl 2():11-4. PubMed ID: 9394854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug and hormone interactions of aromatase inhibitors.
    Dowsett M
    Endocr Relat Cancer; 1999 Jun; 6(2):181-5. PubMed ID: 10731107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The preclinical pharmacology of "Arimidex" (anastrozole; ZD1033)--a potent, selective aromatase inhibitor.
    Dukes M; Edwards PN; Large M; Smith IK; Boyle T
    J Steroid Biochem Mol Biol; 1996 Jul; 58(4):439-45. PubMed ID: 8903429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.
    Sonne-Hansen K; Lykkesfeldt AE
    J Steroid Biochem Mol Biol; 2005 Jan; 93(1):25-34. PubMed ID: 15748829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exemestane, a new steroidal aromatase inhibitor of clinical relevance.
    Lombardi P
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):326-37. PubMed ID: 12084475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatase inhibitors: clinical pharmacology and therapeutic implications in breast cancer.
    Pérez N; Borja J
    J Int Med Res; 1992 Aug; 20(4):303-12. PubMed ID: 1387368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis.
    Mauri D; Pavlidis N; Polyzos NP; Ioannidis JP
    J Natl Cancer Inst; 2006 Sep; 98(18):1285-91. PubMed ID: 16985247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fadrozole and letrozole in advanced breast cancer: clinical and biochemical effects.
    Smith IE; Norton A
    Breast Cancer Res Treat; 1998; 49 Suppl 1():S67-71; discussion S73-7. PubMed ID: 9797020
    [No Abstract]   [Full Text] [Related]  

  • 18. Aromatase inhibitors and their application in breast cancer treatment*.
    Brodie AM; Njar VC
    Steroids; 2000 Apr; 65(4):171-9. PubMed ID: 10713305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aromatase inhibitors: a review of clinical trials].
    Kerbrat P; Lefeuvre C
    Bull Cancer; 2000 Dec; 87 Spec No():31-39. PubMed ID: 11250606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth suppression of MCF-7 human breast cancer cells by aromatase inhibitors: a new system for aromatase inhibitor screening.
    Kitawaki J; Kim T; Kanno H; Noguchi T; Yamamoto T; Okada H
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):667-70. PubMed ID: 8476780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.